Graphic: Kathy Wong for Endpoints News

What kind of biotech start­up wins a $3B syn­di­cate, woos a gallery of mar­quee sci­en­tists and re­cruits GSK's Hal Bar­ron as CEO in a stun­ner? Let Rick Klaus­ner ex­plain

It start­ed with a ques­tion about a life­time’s dream on a walk with tech in­vestor Yuri Mil­ner.

At the be­gin­ning of the great pan­dem­ic, for­mer NCI chief and in­vet­er­ate biotech en­tre­pre­neur Rick Klaus­ner and the Face­book bil­lion­aire would traipse Los Al­tos Hills in Sil­i­con Val­ley Sat­ur­day morn­ings and talk about ideas.

Mil­ner’s ques­tion on one of those morn­ings on foot: “What do you want to do?”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.